Central Sensitization in Patients Seeking Outpatient Physical Therapy Services

May 16, 2025 updated by: Neena Sharma, PT, PhD, CMPT, University of Kansas Medical Center
This is an observational study to examine presence of CS in patients with knee osteoarthritis (OA), chronic LBP (CLBP), and chronic neck pain (CNP) seeking outpatient physical therapy (PT) services. The study will also examine if outcomes differ between patients with CS and patients without CS symptoms with standard PT interventions.

Study Overview

Status

Completed

Detailed Description

Central Sensitization (CS), defined as augmented pain processing, is common in subgroup of nearly all chronic pain conditions, including fibromyalgia, CLBP, OA, and chronic tension headache. However, current studies of CS are primarily limited to research settings, lacking the knowledge about prevalence of CS and rehabilitation outcomes in usual clinical care.

Practicing clinicians do not routinely assess for CS symptoms. Without proper screening for CS, and lack of knowledge of varying levels of nervous system involvement contributing to pain, clinicians are unable to fully identify the depth of the mechanisms and therefore unable to fully determine the best treatment strategies. This observational study addresses this gap in knowledge by screening patients for CS symptoms.

Study Type

Observational

Enrollment (Actual)

77

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kansas
      • Shawnee Mission, Kansas, United States, 66226
        • LifeWorks

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

All subjects over the age of 18 with knee OA, CLBP, and CNP will be asked to consent.

Description

Inclusion Criteria:

  • Diagnosis of knee, neck, or back pain
  • Chronic pain as defined pain > 3 months
  • Able to read and understand English

Exclusion Criteria:

  • Pregnancy
  • Pain less than 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of patients with knee OA, CLBP, and CNP presenting with CS symptoms.
Time Frame: Through study completion, up to 16 weeks
Percentage of patients with knee OA, CLBP, and CNP presenting with CS symptoms.
Through study completion, up to 16 weeks
2011 Fibromyalgia (FM) survey
Time Frame: Through study completion, up to 16 weeks
A standard questionnaire for centralized pain. Scores 3-6 in widespread pain index and 9 or greater in symptom severity suggest widespread pain
Through study completion, up to 16 weeks
Beck Anxiety Inventory
Time Frame: Through study completion, up to 16 weeks
A standard questionnaire with 21 questions. Scores 0-21=low anxiety, scores 22-35=moderate anxiety and scores 36 and above=potentially concerning level of anxiety
Through study completion, up to 16 weeks
Pittsburg sleep scale
Time Frame: Through study completion, up to 16 weeks
A standard questionnaire to examine sleep problems. A total of 5 scores or greater indicate poor sleep quality
Through study completion, up to 16 weeks
Fear Avoidance Questionnaire
Time Frame: Through study completion, up to 16 weeks
A standard questionnaire to examine fear related to work and physical activities.
Through study completion, up to 16 weeks
Lower Extremity Functional Scale (LEFS) for patients with knee OA
Time Frame: Through study completion, up to 16 weeks
LEFS is a 20-question survey about the participant's ability to perform everyday tasks.
Through study completion, up to 16 weeks
Neck Disability Index (NDI) for patients with CNP
Time Frame: Through study completion, up to 16 weeks
NDI is a 10-question survey in which participants check a box corresponding to how their neck pain impacts their activities of daily living.
Through study completion, up to 16 weeks
Oswestry Disability Index (ODI) for patients with CLBP
Time Frame: Through study completion, up to 16 weeks
ODI is a 10-question survey in which participants check a box corresponding to how their low back pain impacts their activities of daily living.
Through study completion, up to 16 weeks
Physical Therapy examination data
Time Frame: Through study completion, up to 16 weeks
Routine PT subjective and objective examination data that includes history taking, range of motion, muscle testing, and neurological exam if necessary
Through study completion, up to 16 weeks
Functional Exam as part of routine primary PT
Time Frame: Through study completion, up to 16 weeks
Routine PT functional assessment includes gait, sit-to-stand, stair climbing, and squats
Through study completion, up to 16 weeks
Neck flexor muscle performance
Time Frame: Through study completion, up to 16 weeks
Strength and endurance. Strength will be tested manually with 0-5 MMT standard grading scale or with use of dynamometer for strength and endurance performance of individual muscles.
Through study completion, up to 16 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Neena Sharma, University of Kansas Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2022

Primary Completion (Actual)

January 22, 2024

Study Completion (Actual)

January 22, 2024

Study Registration Dates

First Submitted

May 16, 2022

First Submitted That Met QC Criteria

July 19, 2022

First Posted (Actual)

July 20, 2022

Study Record Updates

Last Update Posted (Estimated)

May 20, 2025

Last Update Submitted That Met QC Criteria

May 16, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00148639

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Standard Physical Therapy care

Subscribe